RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
EpicentRx, Inc.
EpicentRx, Inc.
University of Rochester
Spanish Lung Cancer Group
AIO-Studien-gGmbH
Guangdong Association of Clinical Trials
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
Eli Lilly and Company
New Mexico Cancer Research Alliance
Vejle Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pierre Fabre Medicament
SWOG Cancer Research Network
SWOG Cancer Research Network
Roswell Park Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University Hospital, Brest
AstraZeneca